• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNational Institutes of Health

National Institutes of Health

Nate Brough, with a mohawk and sunglasses, speaks outside with a blue sky behind him.
Politics
Fired NIH workers fear bleak job prospects in the private sector because their research is too specific to be retrofitted: ‘No VC is going to fund that’
By Sasha RogelbergMarch 11, 2025
People clink wine glasses at a dinner party
Health
The dangers of drinking: Experts explain the 4 ways alcohol can cause cancer
By Lindsey LeakeFebruary 21, 2025
Former federal workers protest against the Department of Government Efficiency helmed by Elon Musk.
Politics
DOGE shut the funding spigot for medical research overnight. Scientists are calling it ‘the end of science’ in America
By Stuart DyosFebruary 21, 2025
A woman takes pills at her desk
Health
The dietary supplements you think are improving your health may be damaging your liver, research warns
By Lindsey LeakeFebruary 18, 2025
An older man wearing a business suit holds a pill in one hand and a glass of water in the other.
Health
The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits
By Lindsey LeakeFebruary 3, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403.
Health
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
By Lindsey LeakeJanuary 11, 2025
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
Health
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
Group of people pouring Champagne into glasses
Health
Just one alcoholic drink a day can increase your risk of cancer. But most Americans don’t know the dangers, new survey says
By Lindsey LeakeDecember 5, 2024
A senior woman measures her blood pressure at home
Health
Hypertension is a ‘silent killer.’ Here’s what your blood pressure should be at every age
By Lindsey LeakeNovember 25, 2024
Compared to other exercise patterns studied, peak physical activity in both the morning and evening was associated with an 11% lower risk of colorectal cancer, according to research published in September 2024 in the journal BMC Medicine.
Health
Working out at these times of day could reduce your risk of colorectal cancer by 11%, new study says
By Lindsey LeakeNovember 11, 2024
In 2024, rapid COVID tests are a staple of cough-and-cold aisles across America. But the convenience of self-testing comes with a caveat: The onus is on you to report your results.
Health
54 million COVID cases went unreported in 2022, study says. Here’s how to make your at-home test count
By Lindsey LeakeOctober 9, 2024
Anthony Fauci
Health
‘Yeah, I was wrong’: Anthony Fauci opens up on his regrets in new PBS ‘American Masters’ documentary
By Mark Kennedy and The Associated PressMarch 21, 2023
Dr. Anthony Fauci
Health
Anthony Fauci tests positive for COVID-19
By Carla K. Johnson and The Associated PressJune 15, 2022
A woman in Bangladesh receiving a COVID-19 vaccine
Health
On the hunt for a ‘universal’ COVID-19 vaccine as Delta variant surges
By Jeremy KahnAugust 18, 2021
1
  • 1
  • 2
2
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.